Cancer Research Technology
Log in Register
Menu

Human Imatinib Mesylate-Resistant Leukemia Cell Line

Info

Catalogue Number 154032
Parental Line BV173
Host Human
Disease Keywords Cancer; Acute Lymphoblastic Leukemia (Ph+ ALL); Chronic Myelogenous Leukemia (CML)
Relevance The human ALL cell line, named BV173, was altered to be imatinib resistant and contains the most frequently observed mutation (E255K) responsible for drug resistance in patients.
Research Area Cancer

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Cormack et al. 1992. J Mol Biol. 228(4):1078-90. PMID: 1474579.

Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro.

Europe PMC ID: 1474579


Add a reference

References: 2 entries

Cormack et al. 1992. J Mol Biol. 228(4):1078-90. PMID: 1474579.

Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor